Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Benin
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Indonesia
  Ireland
  Israel
  Italy
  Jamaica
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lichtenstein
  Lithuania
  Luxembourg
  Madagascar
  Malaysia
  Malta
  Mexico
  Montenegro
  Morocco
  Mozambique
  Namibia
  Netherlands
  New Zealand
  Nigeria
  Norway
  Panama
  Peru
  Poland
  Portugal
  Romania
  Russia
  Senegal
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Sri Lanka
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tanzania
  Thailand
  Tunisia
  Turkey
  Uganda
  Ukraine
  United Kingdom
  United States
  Vietnam


   Infocentre

Last Update: 21-01-2011  
Related category(ies):
Health & life sciences  |  Research policy  |  Pure sciences

 

Add to PDF "basket"

Irish scientists discover how probiotics impact cell physiology

EU-funded researchers in Ireland have discovered that specially designed probiotics can modulate the physiology of host fat cells. Presented in the journal Microbiology, the study was funded in part by the BIOCLA ('Production of CLA [conjugated linoleic acid]-enriched dairy products by natural means') project, which clinched almost EUR 1.7 million under the EU's Fifth Framework Programme (FP5). The findings offer new insight into how specialised probiotics could keep disorders at bay and lead to new treatments.

Bacteria © Shutterstock
Bacteria
©  Shutterstock

The experts from Ireland's Alimentary Pharmabiotic Centre (APC) at University College Cork and Teagasc Moorepark Food Research Centre engineered a strain of Lactobacillus to yield a molecule called CLA. They found a significant change in the composition of fat tissue in tested mice after they ingested this engineered bacterial strain. Thus, ingesting live bacteria can play a critical role in metabolising remote sites in the body, the team concludes.

Various bacteria produce a number of versions of the fatty acid CLA. According to the researchers, one type, called t10, c12 CLA, is linked to decreased body fat in both humans and animals. This particular type can also slow down the growth of colon cancer cells, which could result in the tumour's death. But only some types of bacteria, such as Propionibacterium acnes (P. acnes, the bacterium that triggers acne), produce t10, c12 CLA.

For the purposes of their study, the researchers transferred an enzyme-encoding gene from P. acnes to the Lactobacillus strain, which subsequently produced t10, c12 CLA. The experts said Lactobacillus strains are commonly found in normal gut flora and probiotic products, adding that the level of t10, c12 CLA in the mice's fat tissue increased fourfold when they ingested this recombinant probiotic. Their findings showed that gut microbes affects the host metabolism, especially fat composition.

Commenting on the findings, study leader Dr Catherine Stanton from APC and Teagasc Moorepark Food Research Centre said: 'CLA has already been shown to alleviate non-alcoholic fatty liver disease that often accompanies obesity. Therefore, increasing levels of CLA in the liver by ingestion of a probiotic strain is of therapeutic relevance. Furthermore, fat is not an inert layer around our bodies, it is active and proinflammatory and is a risk factor for many diseases, including cancers. The work shows that there is potential to influence this through diet-microbe-host interactions in the gut.'

The team also discovered that microbially produced CLA could lessen the viability of colon cancer cells by 92%. 'It is possible that a CLA-producing probiotic may also be able to keep colon cancer cells in check,' Dr Stanton said. 'All our findings to date demonstrate that the metabolism of gut bacteria can modulate host cell activity in ways that are beneficial to the host,' she added. 'We need to further investigate the effects of CLA-producing bacteria on human metabolism, but our work so far certainly opens up new possibilities for the use of probiotics for improvement of human health.'


Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Alimentary Pharmabiotic Centre at University College Cork
Teagasc Moorepark Food Research Centre
Microbiology
BIOCLA project





  Top   Research Information Center